These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 31740050)
1. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents. Jan MS; Ahmad S; Hussain F; Ahmad A; Mahmood F; Rashid U; Abid OU; Ullah F; Ayaz M; Sadiq A Eur J Med Chem; 2020 Jan; 186():111863. PubMed ID: 31740050 [TBL] [Abstract][Full Text] [Related]
2. Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition. Sadiq A; Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Rashid U Bioorg Chem; 2021 Jul; 112():104969. PubMed ID: 34023639 [TBL] [Abstract][Full Text] [Related]
3. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity. Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives. Munir A; Khushal A; Saeed K; Sadiq A; Ullah R; Ali G; Ashraf Z; Ullah Mughal E; Saeed Jan M; Rashid U; Hussain I; Mumtaz A Bioorg Chem; 2020 Nov; 104():104168. PubMed ID: 32947133 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives. Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors. Grover J; Kumar V; Sobhia ME; Jachak SM Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899 [TBL] [Abstract][Full Text] [Related]
10. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289 [TBL] [Abstract][Full Text] [Related]
11. Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies. Rashad AY; Kassab SE; Daabees HG; Abdel Moneim AE; Rostom SAF Bioorg Chem; 2021 Aug; 113():104948. PubMed ID: 34052736 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile. Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents. Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies. Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530 [TBL] [Abstract][Full Text] [Related]
16. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study. El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
18. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study. El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586 [TBL] [Abstract][Full Text] [Related]
20. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes. El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]